C. Watson

发表

Diabetic Nephropathy: a Tangled Web to Unweave

D. Brazil, C. Magee, D. Grieve, 2017, Cardiovascular Drugs and Therapy.

Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care

T. Helms, N. Marx, D. Müller-Wieland, 2019, EPMA Journal.

Service evaluation of diabetes management during pregnancy in a regional maternity hospital: potential scope for increased self-management and remote patient monitoring through mHealth solutions

J. O’Donoghue, J. Gallagher, C. Watson, 2019, BMC Health Services Research.

Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?

D. Phelan, P. Collier, C. Watson, 2011, European journal of heart failure.

Epigenetics: The epicenter of the hypoxic response

A. McCann, C. Watson, J. Baugh, 2010, Epigenetics.

Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.

D. Phelan, C. Watson, C. O’loughlin, 2012, Clinical therapeutics.

Biomarker profiling for risk of future heart failure (HFpEF) development

C. Watson, K. McDonald, M. Ledwidge, 2021, Journal of Translational Medicine.

Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up programme

C. Ryan, C. Watson, J. Gilmer, 2021, BMC Cardiovascular Disorders.

Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment

I. Young, L. Kenny, V. Garovic, 2020, The Journal of clinical endocrinology and metabolism.

Cardiovascular risk prediction – are we missing something?

C. Watson, K. McDonald, M. Ledwidge, 2020, European journal of heart failure.

Atrial Tissue Pro‐Fibrotic M2 Macrophage Marker CD163+, Gene Expression of Procollagen and B‐Type Natriuretic Peptide

D. Phelan, P. Collier, C. Watson, 2020, Journal of the American Heart Association.

Reducing Heart Failure Risk In People With Diabetes - the STOP HF Midlands Project.

C. Watson, K. McDonald, J. Gallagher, 2019, Journal of cardiac failure.

Natriuretic Peptide-based Screening and Prevention of Heart Failure.

C. Watson, K. McDonald, M. Ledwidge, 2017, Cardiac failure review.

Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis.

C. Watson, S. Horgan, K. McDonald, 2015, Journal of cardiac failure.

Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure

C. Watson, K. McDonald, D. O'Shea, 2016, Biomarkers.

FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease

A. Keech, A. Jenkins, A. Januszewski, 2020, Scientific Reports.

Machine Learning–Based Risk Assessment for Cancer Therapy–Related Cardiac Dysfunction in 4300 Longitudinal Oncology Patients

M. Chung, F. Cheng, Yadi Zhou, 2020, Journal of the American Heart Association.

A systematic review of clinical prediction rules for the diagnosis of chronic heart failure

C. Watson, K. McDonald, M. Ledwidge, 2019, ESC heart failure.

Biomarker Testing and Pre-emptive Therapy in Preventing Heart Failure

C. Watson, K. McDonald, M. Ledwidge, 2015, Current Cardiovascular Risk Reports.

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.

C. Watson, K. McDonald, V. Voon, 2013, JAMA.

Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease

P. Collier, C. Watson, S. Horgan, 2015, Journal of Cardiovascular Translational Research.

Risk of pre‐eclampsia in women taking metformin: a systematic review and meta‐analysis

T. Lyons, C. Watson, A. Alqudah, 2018, Diabetic medicine : a journal of the British Diabetic Association.

Heart failure in sub‐Saharan Africa: review of the aetiology of heart failure and the role of point‐of‐care biomarker diagnostics

J. O’Donoghue, C. Watson, K. McDonald, 2015, Tropical medicine & international health : TM & IH.

Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting

A. J. Wilson, D. Grieve, C. Watson, 2017, Heart.

Life expectancy for community-based patients with heart failure from time of diagnosis.

M. Hensey, C. Watson, K. McDonald, 2015, International journal of cardiology.

426 A systematic review of clinical prediction rules to diagnose bacterial lower respiratory infection in children in primary care and their validation in a new cohort

C. Watson, M. Ledwidge, J. Gallagher, 2021, Abstracts.

NOX 4 is a major regulator of cord blood-derived endothelial colony-forming cells which promotes post-ischaemic revascularization

Alan W. Stitt, M. Yoder, R. Medina, 2019 .

NOX4 is a major regulator of cord blood-derived endothelial colony-forming cells which promotes postischaemic revascularisation.

Alan W. Stitt, M. Yoder, R. Medina, 2019, Cardiovascular research.

Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients with Cancer.

F. Cheng, M. Desai, L. Svensson, 2020, The American journal of cardiology.

FKBPL and SIRT-1, key angiogenesis proteins, are downregulated by diabetes in pregnancy

I. Young, D. Grieve, C. Watson, 2020, medRxiv.

Pre-Eclampsia Biomarkers for Women With Type 1 Diabetes Mellitus: A Comprehensive Review of Recent Literature

C. Watson, K. Eastwood, Katrina Z. Freimane, 2022, Frontiers in Bioengineering and Biotechnology.

Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.

D. Phelan, C. Watson, K. McDonald, 2009, Journal of the American College of Cardiology.

Associates of an Elevated Natriuretic Peptide Level in Stable Heart Failure Patients: Implications for Targeted Management

P. Collier, C. Watson, K. McDonald, 2013, TheScientificWorldJournal.

Sacubitril‐Valsartan in a routine community population: attention to volume status critical to achieving target dose

A. Maisel, C. Watson, K. McDonald, 2020, ESC heart failure.

Generation of an epigenetic signature by chronic hypoxia in prostate cells.

J. O’Sullivan, A. Murrell, A. McCann, 2009, Human molecular genetics.

Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community

J. Januzzi, C. Watson, K. McDonald, 2020, Journal of cellular and molecular medicine.

Mechanical stretch up-regulates the B-type natriuretic peptide system in human cardiac fibroblasts: a possible defense against transforming growth factor-β mediated fibrosis

D. Phelan, P. Collier, C. Watson, 2012, Fibrogenesis & tissue repair.

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up

J. Crown, C. Watson, G. Gullo, 2016, Breast Cancer Research and Treatment.

Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure.

C. Ryan, C. Watson, K. McDonald, 2018, The Cochrane database of systematic reviews.

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme

C. Ryan, C. Watson, M. Barrett, 2021, ESC heart failure.

Sarcoidosis, alveolar β-actin and pulmonary fibrosis.

M. Keane, D. O’Dwyer, S. Donnelly, 2013, QJM : monthly journal of the Association of Physicians.

Translational Science Sarcoidosis, alveolar b-actin and pulmonary fibrosis

M. Keane, D. O’Dwyer, S. Donnelly, 2013 .

Extracellular matrix sub-types and mechanical stretch impact human cardiac fibroblast responses to transforming growth factor beta

D. Phelan, P. Collier, C. Watson, 2014, Connective tissue research.

TF-GCTS140011 248..256

D. Phelan, P. Collier, C. Watson, 2014 .

Association of Bacille Calmette-Guerin (BCG), Adult Pneumococcal and Adult Seasonal Influenza Vaccines with Covid-19 Adjusted Mortality Rates in Level 4 European countries

C. Watson, J. Gallagher, M. Ledwidge, 2020, medRxiv.

Cardiomyopathy in Offspring of Pregestational Diabetic Mouse Pregnancy

P. Downey, F. Mcauliffe, C. Watson, 2014, Journal of diabetes research.

Sarcoidosis , alveolar b-actin and pulmonary fibrosis

M. Keane, D. O’Dwyer, S. Donnelly, 2013 .

HIF-1-Dependent TGM1 Expression is Associated with Maintenance of Airway Epithelial Junction Proteins

Lili Li, C. Watson, J. Baugh, 2016, Lung.

Aortic Valve Calcium in Patients With Transthyretin Cardiac Amyloidosis: A Propensity-Matched Analysis.

P. Schoenhagen, B. Griffin, C. Jellis, 2020, Circulation. Cardiovascular imaging.

Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care

T. Helms, N. Marx, D. Müller-Wieland, 2019, EPMA Journal.

Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis

C. Watson, S. Horgan, K. McDonald, 2016, Journal of cardiovascular pharmacology and therapeutics.

Epigenetic Regulation of Endothelial Cell Function by Nucleic Acid Methylation in Cardiac Homeostasis and Disease

D. Grieve, C. Watson, A. Russell-Hallinan, 2020, Cardiovascular Drugs and Therapy.

Epigenetics of Aberrant Cardiac Wound Healing.

C. Watson, J. Baugh, A. Russell-Hallinan, 2018, Comprehensive Physiology.

Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype.

D. Phelan, P. Collier, A. McCann, 2014, Human molecular genetics.

MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure

T. Thum, C. Watson, Shashi K. Gupta, 2015, European journal of heart failure.

Importance of risk factor management in diabetic patients and reduction in Stage B heart failure.

J. Griffin, J. O’ Connell, C. Watson, 2015, QJM : monthly journal of the Association of Physicians.

Repurposing From Oncology to Cardiology: Low-Dose 5-Azacytidine Attenuates Pathological Cardiac Remodeling in Response to Pressure Overload Injury

C. Watson, J. Baugh, A. Russell-Hallinan, 2020, Journal of cardiovascular pharmacology and therapeutics.

Attenuation of Monocyte Chemotaxis—A Novel Anti-inflammatory Mechanism of Action for the Cardio-protective Hormone B-Type Natriuretic Peptide

P. Collier, C. Watson, K. McDonald, 2013, Journal of Cardiovascular Translational Research.

Cost‐effectiveness of natriuretic peptide‐based screening and collaborative care: a report from the STOP‐HF (St Vincent's Screening TO Prevent Heart Failure) study

L. Tilson, C. Watson, K. McDonald, 2015, European journal of heart failure.

Proteomic Analysis of Coronary Sinus Serum Reveals Leucine-Rich &agr;2-Glycoprotein as a Novel Biomarker of Ventricular Dysfunction and Heart Failure

M. Dunn, D. Phelan, P. Collier, 2011, Circulation. Heart failure.

Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis

C. Watson, J. Baugh, Roisín Neary, 2015, Fibrogenesis & tissue repair.

Targeted DNA Methylation Profiling of Human Cardiac Tissue Reveals Novel Epigenetic Traits and Gene Deregulation Across Different Heart Failure Patient Subtypes

D. Phelan, P. Collier, W. Gallagher, 2019, Circulation. Heart failure.

Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype

C. Watson, J. Baugh, Claire M. Robinson, 2012, Respiratory Research.

Epigenetics within the matrix

C. Watson, J. Baugh, Claire M. Robinson, 2012, Epigenetics.

Cardiac risk stratification in cancer patients: A longitudinal patient–patient network analysis

M. Chung, F. Cheng, Yadi Zhou, 2021, PLoS medicine.

Discovery of Novel Caeridins from the Skin Secretion of the Australian White's Tree Frog, Litoria caerulea

C. Watson, Xinping Xi, Tianbao Chen, 2018, International journal of genomics.

A Central Role for Monocyte–Platelet Interactions in Heart Failure

C. Watson, J. Gilmer, M. Ledwidge, 2016, Journal of cardiovascular pharmacology and therapeutics.

Developing a disease management program for the improvement of heart failure outcomes: the do’s and the don’ts

C. Watson, K. McDonald, M. Ledwidge, 2019, Expert review of cardiovascular therapy.

Diabetes and complications of the heart in Sub-Saharan Africa: An urgent need for improved awareness, diagnostics and management.

C. Watson, K. McDonald, M. Ledwidge, 2018, Diabetes research and clinical practice.

Murine models of diastolic dysfunction and heart failure with preserved ejection fraction.

C. Watson, S. Horgan, J. Baugh, 2014, Journal of cardiac failure.

Modest Elevation in BNP in Asymptomatic Hypertensive Patients Reflects Sub-Clinical Cardiac Remodeling, Inflammation and Extracellular Matrix Changes

D. Phelan, P. Collier, S. Donnelly, 2012, PloS one.

Heart Failure in Sub-Saharan Africa.

C. Watson, K. McDonald, M. Ledwidge, 2018, Cardiac failure review.

Cardiac sub-volume targeting demonstrates regional radiosensitivity in the mouse heart.

M. V. van Herk, M. Aznar, A. McWilliam, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension

C. Watson, K. McDonald, M. Ledwidge, 2018, American journal of hypertension.

Heart Failure Virtual Consultation: bridging the gap of heart failure care in the community ‐ A mixed‐methods evaluation

C. Watson, K. McDonald, M. Ledwidge, 2017, ESC heart failure.

A comparison of HFrEF vs HFpEF's clinical workload and cost in the first year following hospitalization and enrollment in a disease management program.

C. Watson, K. McDonald, T. Murphy, 2017, International journal of cardiology.

Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre–Heart Failure With Preserved Ejection Fraction

J. Dodd, C. Watson, K. McDonald, 2023, JAMA cardiology.

New‐onset heart failure in the STOP‐HF programme. Natriuretic peptide defines and tracks risk and enables earlier diagnosis of heart failure

C. Watson, K. McDonald, J. Gallagher, 2020, European journal of heart failure.

Implementing Innovative Approaches to Healthcare in a Lower-Middle Income Country: Perspectives from Malawi

S. Taylor-Robinson, J. Gallagher, C. Watson, 2020, International journal of general medicine.

FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function

I. Young, D. Grieve, C. Watson, 2021, Frontiers in Endocrinology.

A Systematic Review of Clinical Prediction Rules to Predict Hospitalisation in Children with Lower Respiratory Infection in Primary Care and their Validation in a New Cohort

C. Watson, R. Drew, M. Ledwidge, 2021, EClinicalMedicine.

Salivary Biomarkers for Diagnosis and Therapy Monitoring in Patients with Heart Failure. A Systematic Review

D. Fotiadis, A. Errachid, M. Trivella, 2021, Diagnostics.

Impact of timing of atrial fibrillation, CHA2DS2-VASc score and cancer therapeutics on mortality in oncology patients

Andrew J. Toth, F. Cheng, B. Griffin, 2020, Open Heart.

Effectiveness of family-based eHealth interventions in cardiovascular disease risk reduction: A systematic review.

J. Woodside, D. Thompson, C. Ski, 2021, Preventive medicine.

Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis

P. Collier, C. Watson, K. McDonald, 2020, Scientific Reports.

Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction

P. Collier, C. Watson, M. Harbinson, 2022, Cardiovascular research.

Biomarker profiling for risk of future heart failure (HFpEF) development

C. Watson, K. McDonald, M. Ledwidge, 2021, Journal of translational medicine.

A Machine Learning Approach for Chronic Heart Failure Diagnosis

D. Fotiadis, K. Naka, L. Michalis, 2021, Diagnostics.

ECSIT is a critical limiting factor for cardiac function

D. Stolz, D. Grieve, C. Watson, 2021, JCI insight.

Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure

C. Watson, K. McDonald, D. O'Shea, 2016, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

A systematic review of clinical prediction rules for the diagnosis of chronic heart failure

C. Watson, K. McDonald, M. Ledwidge, 2019, ESC heart failure.

Epigenetics and the overhealing wound: the role of DNA methylation in fibrosis

C. Watson, J. Baugh, Roisín Neary, 2015, Fibrogenesis & tissue repair.

Heart Failure diagnosis based on deep learning techniques

D. Fotiadis, K. Naka, E. Tripoliti, 2021, 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC).